Literature DB >> 729118

Studies on the fate of naproxen. II. Metabolic fate in various animals and man.

Y Sugawara, M Fujihara, Y Miura, K Hayashida, T Takahashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 729118     DOI： 10.1248/cpb.26.3312

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of naproxen.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

2.  Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.

Authors:  E J Franssen; R G van Amsterdam; J Visser; F Moolenaar; D de Zeeuw; D K Meijer
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

3.  Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.

Authors:  E J Franssen; F Moolenaar; D de Zeeuw; D K Meijer
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

4.  In Vivo Functional Effects of CYP2C9 M1L, a Novel and Common Variant in the Yup'ik Alaska Native Population.

Authors:  Lindsay M Henderson; Scarlett E Hopkins; Bert B Boyer; Timothy A Thornton; Allan E Rettie; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2021-02-25       Impact factor: 3.922
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.